Not applicableUnknownNCT05446935What this trial is testingIntrathoracic Chemotherapy for TETs With Pleural Spread or RecurrenceWho this might be right forThymic Epithelial Tumor Shanghai Zhongshan Hospital 37
Not applicableStudy completedNCT03288662What this trial is testingRelationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial TumorsWho this might be right forThymoma Military Hospital 103 2
Early research (Phase 1)Study completedNCT00314873What this trial is testingPilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic CarcinomaWho this might be right forThymic Carcinoma Indiana University School of Medicine 11
Testing effectiveness (Phase 2)Looking for participantsNCT06311968What this trial is testingThe Clinical Study of Post-operative Proton Radiotherapy for Thymus TumorWho this might be right forThymus Epithelial TumorProton RadiotherapyRadiation Toxicity Jian Chen 55
Not applicableLooking for participantsNCT06941584What this trial is testingAnalysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With AutoantibodiesWho this might be right forAIRE Deficiency Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Testing effectiveness (Phase 2)Study completedNCT00589290What this trial is testingBelinostat (PXD101) to Treat Tumors of the Thymus at an Advanced StageWho this might be right forThymomaThymic Carcinoma National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00003662What this trial is testingUmbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Roswell Park Cancer Institute 90
Large-scale testing (Phase 3)Looking for participantsNCT06402708What this trial is testingPostoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)Who this might be right forThymic Carcinoma Fudan University 172
Testing effectiveness (Phase 2)Temporarily pausedNCT03704714What this trial is testingNivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell LymphomaWho this might be right forAggressive Non-Hodgkin LymphomaB-Cell Non-Hodgkin LymphomaCD20 Positive+5 more Northwestern University 30
Testing effectiveness (Phase 2)Ended earlyNCT04469725What this trial is testingKN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic CarcinomaWho this might be right forThymic Carcinoma Jiangsu Alphamab Biopharmaceuticals Co., Ltd 95
Early research (Phase 1)Ended earlyNCT01165658What this trial is testingStudy of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesWho this might be right forNon-small Cell Lung CancerSmall Cell Lung CancerCarcinoid+2 more M.D. Anderson Cancer Center 30
Not applicableNot Yet RecruitingNCT07328074What this trial is testingElectrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural MetastasisWho this might be right forThymic Epithelial TumorThymomaThymic Carcinoma+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT05832827What this trial is testingFirst-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)Who this might be right forUntreated Advanced or Recurrent Thymic Carcinomas National Cancer Center, Japan 35
Early research (Phase 1)Ended earlyNCT05169489What this trial is testingBbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)Who this might be right forDiffuse Large B Cell Lymphoma (DLBCL) Regeneron Pharmaceuticals 15
Not applicableStudy completedNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 72
Early research (Phase 1)Study completedNCT02924402What this trial is testingStudy to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesWho this might be right forB-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia Xencor, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT04432506What this trial is testingAnakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell LymphomaWho this might be right forHematopoietic and Lymphoid Cell NeoplasmRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+6 more M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Not applicableLooking for participantsNCT04822077What this trial is testingStudy on Proton Radiotherapy of Thymic MalignanciesWho this might be right forCardiotoxicityPulmonary ToxicityThymus Neoplasms Ass. Prof. Jan Nyman 40
Testing effectiveness (Phase 2)Study completedNCT01325441What this trial is testingBBI608 Administered With Paclitaxel in Adult Patients With Advanced MalignanciesWho this might be right forCancer Sumitomo Pharma America, Inc. 565